Precision for Medicine’s Jared Kohler and Tobias Guennel highlight the challenges for researchers pursuing biomarkers and specialty lab data that meet new FDA regulatory standards. Kohler and Guennel discuss how to leverage new technologies and subject matter expertise to improve efficiency and compliance.

To read the complete article, please click here.